Intestinal Research

Tumor
Clinical characteristics and risk factors related to polyposis recurrence and advanced neoplasm development among patients with non-hereditary colorectal polyposis: Jihun Jang, Jihye Park, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Tae Il Kim; Intest Res. 2023;21(4):510-517. Published online May 31, 2023; DOI: https://doi.org/10.5217/ir.2022.00139; Full text PubReader ePub PDF

The elderly population are more vulnerable for the management of colorectal cancer during the COVID-19 pandemic: a nationwide, population-based study: Hong Sun Kang, Seung Hoon Jeon, Su Bee Park, Jin Young Youn, Min Seob Kwak, Jae Myung Cha; Intest Res. 2023;21(4):500-509. Published online August 29, 2023; DOI: https://doi.org/10.5217/ir.2023.00004
Cited By 1; Full text PubReader ePub PDF Supplementary Material

Infection
How the COVID-19 pandemic affected the severity and clinical presentation of diverticulitis: Sara S. Soliman, Rolando H. Rolandelli, Grace C. Chang, Amanda K. Nemecz, Zoltan H. Nemeth; Intest Res. 2023;21(4):493-499. Published online October 26, 2023; DOI: https://doi.org/10.5217/ir.2022.00042; Full text PubReader ePub PDF

Comparative outcomes of acute colonic diverticulitis in immunocompromised versus immunocompetent patients: a systematic review and meta-analysis: Jae Gon Lee, Yong Eun Park, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Shin Hee Lee, Myung-Won You, Seong-Eun Kim; Intest Res. 2023;21(4):481-492. Published online May 31, 2023; DOI: https://doi.org/10.5217/ir.2023.00005
Cited By 1; Full text PubReader ePub PDF Supplementary Material

IBD
Malnutrition and inflammation status in nonobese patients with inflammatory bowel disease are associated with nonalcoholic fatty liver disease: a retrospective study: Takahiro Nagata, Sadahiro Funakoshi, Daisuke Morihara, Satoshi Shakado, Keiji Yokoyama, Kazuhide Takata, Takashi Tanaka, Atsushi Fukunaga, Ryo Yamauchi, Hiromi Fukuda, Hiroki Matsuoka, So Imakiire, Hideto Sakisaka, Satoshi Matsuoka, Nobuaki Kuno, Koichi Abe, Hideki Ishibashi, Shinya Ashizuka, Fumihito Hirai; Intest Res. 2023;21(4):471-480. Published online August 11, 2023; DOI: https://doi.org/10.5217/ir.2023.00035; Full text PubReader ePub PDF

Serum albumin is the strongest predictor of anti-tumor necrosis factor nonresponse in inflammatory bowel disease in resource-constrained regions lacking therapeutic drug monitoring: Peeyush Kumar, Sudheer K. Vuyyuru, Prasenjit Das, Bhaskar Kante, Mukesh Kumar Ranjan, David Mathew Thomas, Sandeep Mundhra, Pabitra Sahu, Pratap Mouli Venigalla, Saransh Jain, Sandeep Goyal, Rithvik Golla, Shubi Virmani, Mukesh K. Singh, Karan Sachdeva, Raju Sharma, Nihar Ranjan Dash, Govind Makharia, Saurabh Kedia, Vineet Ahuja; Intest Res. 2023;21(4):460-470. Published online March 17, 2023; DOI: https://doi.org/10.5217/ir.2022.00128
Cited By 1; Full text PubReader ePub PDF Supplementary Material

Low prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease in India: Arshdeep Singh, Vandana Midha, Vikram Narang, Saurabh Kedia, Ramit Mahajan, Pavan Dhoble, Bhavjeet Kaur Kahlon, Ashvin Singh Dhaliwal, Ashish Tripathi, Shivam Kalra, Narender Pal Jain, Namita Bansal, Rupa Banerjee, Devendra Desai, Usha Dutta, Vineet Ahuja, Ajit Sood; Intest Res. 2023;21(4):452-459. Published online December 2, 2022; DOI: https://doi.org/10.5217/ir.2022.00087
Cited By 3; Full text PubReader ePub PDF

Tumor
Summary and comparison of recently updated post-polypectomy surveillance guidelines: Yoon Suk Jung; Intest Res. 2023;21(4):443-451. Published online October 26, 2023; DOI: https://doi.org/10.5217/ir.2023.00107; Full text PubReader ePub PDF

Microbiota
Gut microbiome on immune checkpoint inhibitor therapy and consequent immune-related colitis: a review: Sung Wook Hwang, Min Kyu Kim, Mi-Na Kweon; Intest Res. 2023;21(4):433-442. Published online August 29, 2023; DOI: https://doi.org/10.5217/ir.2023.00019; Full text PubReader ePub PDF

IBD
Treatment of primary sclerosing cholangitis combined with inflammatory bowel disease: You Sun Kim, Edward H. Hurley, Yoojeong Park, Sungjin Ko; Intest Res. 2023;21(4):420-432. Published online September 1, 2023; DOI: https://doi.org/10.5217/ir.2023.00039; Full text PubReader ePub PDF

Tumor
To overcome medical gap in screening and surveillance of colorectal cancer during the COVID-19 pandemic: Yoo Min Han; Intest Res. 2023;21(4):418-419. Published online October 26, 2023; DOI: https://doi.org/10.5217/ir.2023.00144; Full text PubReader ePub PDF

Infection
Not all acute colonic diverticulitis follows the same course: a potential risk for immunocompromised individuals: Yehyun Park; Intest Res. 2023;21(4):415-417. Published online October 26, 2023; DOI: https://doi.org/10.5217/ir.2023.00142; Full text PubReader ePub PDF

IBD
Regional variations in the prevalence of primary sclerosing cholangitis associated with inflammatory bowel disease: Kwang Woo Kim, Hyoun Woo Kang; Intest Res. 2023;21(4):413-414. Published online October 26, 2023; DOI: https://doi.org/10.5217/ir.2023.00133; Full text PubReader ePub PDF

Miscellaneous
JAK inhibitor, a new player for treatment-refractory microscopic colitis: Anne Druez, Simon Travis, Jean-François Rahier; Intest Res. 2023;21(3):411-412. Published online July 4, 2023; DOI: https://doi.org/10.5217/ir.2023.00030; Full text PubReader ePub PDF

IBD
Clinical features of enteric and colo-duodenal fistula in patients with Crohn’s disease: Jun Su Lee, Sang-Bum Kang, Kwangbeom Park, Yong Sik Yoon, Chang Sik Yu, Sung Wook Hwang, Byong Duk Ye, Suk-Kyun Yang, Jong Lyul Lee, Sang Hyoung Park; Intest Res. 2023;21(3):406-410. Published online February 22, 2023; DOI: https://doi.org/10.5217/ir.2022.00125; Full text PubReader ePub PDF Supplementary Material

Article category